S02_JnA_Q0008.pdf
PDF 528 KB Posted
- Solicitation number
- 36C77022Q0008
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C77022Q0008_1.docx | DOCX document | |
| S02_Pricing Schedule_Q0008.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
VHAPM Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source
Attachment 1: Single Source Justification for SAP under the SAT
DEPARTMENT OF VETERANS AFFAIRS
Justification for Single Source Awards IAW FAR 13.106-1
For
Over Micro-Purchase Threshold but Not Exceeding the SAT ($2SOK)
Acquisition Plan Action ID: 36C770-22-AP-0013
1. Contracting Activity: Department of Veterans Affairs, NCO 15, National CMOP Contracting Office.
2237 # 766-22-1-400-0030, Charleston CMOP, Charleston, SC.
2. Brief Description of Supplies/Services required and the intended use/Estimated Amount:
Item File Description guantitv Unit of Packaging
Number Number Measure Multiple
0001 16025 SET, IN FUSI ON AUTOSOFT 1500 BX 10
90 TANDEM #1002817
10CTXJ652
This is an individual brand name justification to support the procurement of the Med Surg items in the table above. The proposed procurement action will be a firm-fixed-price contract award for the supplies.
3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:
Product has been prescribed for patients by VA Physicians. Pharmacy employees do not have the training and/or authority to countermand physician orders. "Brand Specific" products are the same thing as "dispense as written" on a physician's prescription. No National Drug Code (NDC) substitutions are permitted. In the VA, Pharmacy Benefits Management (PBM) has determined that
CMOP IDs in the National Drug File (NDF) will most always identify "brand specific" products in the
VA PRINT NAME. This is not always inclusive where a particular NDC has been determined to be
"formulation specific" by clinical evaluation performed by the PBM or in the case where only one product in the marketplace has been identified to contain the specific ingredients to match the product code.
VHAPM Part 813.106
Original Date: 08/30/17
Revision 02 Eff Date: 03/31/2020
File details come from the government source that posted it. Updated .